Sandoz Inc. v. Amgen Inc.
| SANDOZ INC. |
| AMGEN INC., AMGEN MANUFACTURING LIMITED LLC and IMMUNEX CORPORATION |
| WASHINGTON LEGAL FOUNDATION, PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, BIOTECHNOLOGY INNOVATION ORGANIZATION and HONORABLE PAUL R. MICHEL, (RET.) |
| 26-1309 |
| March 19, 2026 |
| U.S. Court of Appeals, Fourth Circuit |
| Antitrust |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 14, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 47 Additional copies of the AMICUS BRIEF received from Washington Legal Foundation. Number of copies: [4]. [1002053716] [26-1309] KS [Entered: 09/14/2026 02:48 PM] |
| Filing 45 RESPONSE/ANSWER by Paul R. Michel to Notice requesting response to similar case inquiry. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. [1002052743] [26-1309] Matthew Dowd [Entered: 09/11/2026 03:07 PM] |
| Filing 44 RESPONSE/ANSWER by Washington Legal Foundation to Notice requesting response to similar case inquiry. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. [1002052687] [26-1309] Jerome DeSanto [Entered: 09/11/2026 02:39 PM] |
| Filing 43 RESPONSE/ANSWER by Sandoz Inc. to Notice requesting response to similar case inquiry. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. [1002052620] [26-1309] Matthew Kent [Entered: 09/11/2026 01:57 PM] |
| Filing 42 NOTICE REGARDING CONFLICT WITH PROPOSED ARGUMENT DATES by Appellant Sandoz Inc.. Argument Session: December 8-11, 2026. Days you are available: December 8-9.. . [1002052616] [26-1309] Matthew Kent [Entered: 09/11/2026 01:53 PM] |
| Filing 41 RESPONSE/ANSWER by Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization to Notice requesting response to similar case inquiry. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. [1002052573] [26-1309] Andrew Lazerow [Entered: 09/11/2026 01:21 PM] |
| Filing 40 RESPONSE/ANSWER by Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation to Notice requesting response to similar case inquiry. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. [1002051964] [26-1309] Elaine Goldenberg [Entered: 09/10/2026 04:28 PM] |
| Filing 39 NOTICE ISSUED to Biotechnology Innovation Organization, Paul R. Michel, Pharmaceutical Research and Manufacturers of America, Washington Legal Foundation, Sandoz Inc. and Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation requesting response to similar case(s) question [1002049671]. Response to similar case notice due 09/11/2026. [26-1309] TW [Entered: 09/08/2026 01:14 PM] |
| Filing 38 CASE TENTATIVELY CALENDARED for oral argument during the December 8-11, 2026, argument session. Notify Clerk's Office of any scheduling conflict by: 09/15/2026. Any required additional copies of briefs and joint appendices are due 09/15/2026. [1002049591] [26-1309] SCC [Entered: 09/08/2026 12:29 PM] |
| Filing 37 BRIEF by Sandoz Inc.. Type of Brief: REPLY. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1002017832] [26-1309] Matthew Kent [Entered: 07/20/2026 02:04 PM] |
| Filing 34 DISCLOSURE STATEMENT by Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. Was any question on Disclosure Form answered yes? No. [1002015961] [26-1309] KS [Entered: 07/16/2026 02:22 PM] |
| Filing 33 DISCLOSURE STATEMENT by Washington Legal Foundation. Was any question on Disclosure Form answered yes? No. [1002010348] [26-1309] TW [Entered: 07/08/2026 12:40 PM] |
| Filing 32 APPEARANCE OF COUNSEL by Jerome P. DeSanto for Washington Legal Foundation. [1002010343] [26-1309]--[Edited 07/14/2026 by KS - added attorney name to docket text] TW [Entered: 07/08/2026 12:39 PM] |
| Filing 31 APPEARANCE OF COUNSEL by Andrew Lazerow for Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. [1002010336] [26-1309]--[Edited 07/14/2026 by KS - added attorney name to docket text] TW [Entered: 07/08/2026 12:36 PM] |
| Filing 30 APPEARANCE OF COUNSEL by Matthew J. Dowd for Paul R. Michel. [1002010334] [26-1309]--[Edited 07/14/2026 by KS - added attorney name to docket text] TW [Entered: 07/08/2026 12:35 PM] |
Filing 29
ORDER filed granting filing of amicus curiae brief. Disclosure Statement filed (if corporate amicus)? Y. Appearance Form filed? Y. Copies to all parties. [1002010317] [26-1309] TW [Entered: 07/08/2026 12:22 PM]
|
| Filing 36 Receipt of paper copy of AMICUS BRIEF filed at [ # 28 ] by Honorable Paul R. Michel (ret.). Number of pages: [40]. Sufficient: Yes. Number of copies: [1]. Received by clerk date: 07/08/2026. [1002015982] [26-1309] KS [Entered: 07/16/2026 02:31 PM] |
| Filing 28 AMICUS CURIAE BRIEF by Honorable Paul R. Michel (ret.). . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. Response: Appeal No. 26-1473 (4th Cir.) may raise similar issues.. [1002009586] [26-1309] Matthew Dowd [Entered: 07/07/2026 04:00 PM] |
| Filing 46 Receipt of paper copy of AMICUS BRIEF filed at [ # 27 ] by Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. Number of pages: [38]. Sufficient: Yes. Number of copies: [4]. Received by clerk date: 09/09/2026. [1002053711] [26-1309] KS [Entered: 09/14/2026 02:44 PM] |
| Filing 35 Receipt of paper copy of AMICUS BRIEF filed at [ # 26 ] by Washington Legal Foundation. Number of pages: [28]. Sufficient: Yes. Number of copies: [1]. Received by clerk date: 07/07/2026. [1002015972] [26-1309] KS [Entered: 07/16/2026 02:26 PM] |
| Filing 27 AMICUS CURIAE BRIEF by Amici Curiae Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. Response: CareFirst made antitrust allegations against Amgen similar to those made by Sandoz. Issues here, e.g., the role of injunctions in a causal chain and whether patent applications can be exclusionary, also arise in the CareFirst appeal (No. 26-1473). [1002008874] [26-1309] Andrew Lazerow [Entered: 07/06/2026 06:43 PM] |
| Filing 26 AMICUS CURIAE BRIEF by Washington Legal Foundation (Amicus Curiae). . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. Response: CareFirst v. Amgen (No. 26-1473). Similar issues raised include (i) whether acquisition of rights to patent applications can be exclusionary conduct; (ii) whether injunctions break causal chain for purposes of antitrust claims. [1002008796] [26-1309] Jerome DeSanto [Entered: 07/06/2026 10:29 AM] |
|
Filing 25
ORDER filed deferring action on Motion to Schedule Oral Argument in Nos. 26-1309 & 26-1473 on the Same Date and Before the Same Panel filed by Appellees Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation [ # 24 ]. Copies to all parties. [1002007324] [26-1309] KS [Entered: 07/01/2026 10:32 AM]
|
| Filing 24 MOTION by Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation to Schedule Oral Argument in Nos. 26-1309 & 26-1474 on the Same Date and Before the Same Panel.. Date and method of service: 06/30/2026 ecf. [1002007047] [26-1309] Elaine Goldenberg [Entered: 06/30/2026 05:01 PM] |
| Filing 48 Receipt of paper copy of RESPONSE BRIEF filed at [ # 23 ] by Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. Number of pages: [76]. Sufficient: YES. Number of Copies: [4]. Received by clerk date: 09/11/2026. [1002053740] [26-1309] KS [Entered: 09/14/2026 03:05 PM] |
| Filing 23 BRIEF by Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. Type of Brief: RESPONSE. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. Response: CareFirst made antitrust allegations against Amgen similar to Sandoz's. Issues here (e.g., significance of injunctions in a causal chain and whether rights to patent applications can be exclusionary) also arise in the CareFirst appeal (No.26-1473). [1002006011] [26-1309] Elaine Goldenberg [Entered: 06/29/2026 05:34 PM] |
|
Filing 22
ORDER filed granting motion to extend filing time [ # 19 ]. Number of days granted: 32. Response brief due 06/29/2026. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. Copies to all parties. [1001977092] [26-1309] TW [Entered: 05/12/2026 10:11 AM]
|
| Filing 21 RESPONSE/ANSWER by Sandoz Inc. to Motion to extend filing time [ # 19 ]. [1001976852] [26-1309] Matthew Kent [Entered: 05/11/2026 04:47 PM] |
| Filing 20 NOTICE ISSUED to Sandoz Inc. requesting response to motion to extend filing time [ # 19 ]. Response due: 05/12/2026 [1001975716]. [26-1309] TW [Entered: 05/08/2026 02:18 PM] |
| Filing 19 MOTION by Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation to extend filing time for response brief until June 29, 2026.. Date and method of service: 05/08/2026 ecf. [1001975579] [26-1309] Elaine Goldenberg [Entered: 05/08/2026 12:17 PM] |
| Filing 18 JOINT APPENDIX by Sandoz Inc.. Digital media exhibit volume? No. [1001968908] [26-1309] Matthew Kent [Entered: 04/28/2026 02:02 PM] |
| Filing 17 BRIEF by Sandoz Inc.. Type of Brief: OPENING. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? YES. Response: Sandoz and Carefirst both alleged antitrust claims as to Amgen's anticompetitive conduct involving its branded etanercept drug. But this appeal raises a single legal question that is not at issue in CareFirst of Maryland, Inc. v. Amgen, Inc., No. 26-1473. [1001968906] [26-1309] Matthew Kent [Entered: 04/28/2026 02:00 PM] |
| Filing 16 APPEARANCE OF COUNSEL by Rohit Singla for Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. [1001965405] [26-1309] Rohit Singla [Entered: 04/22/2026 06:08 PM] |
| Filing 15 APPEARANCE OF COUNSEL by Troy A Stram for Sandoz Inc.. [1001956922] [26-1309] Troy Stram [Entered: 04/08/2026 10:08 AM] |
| Filing 14 DOCKETING STATEMENT by Sandoz Inc... [1001954106] [26-1309] Matthew Kent [Entered: 04/02/2026 09:11 AM] |
| Filing 13 DISCLOSURE STATEMENT by Sandoz Inc.. Was any question on Disclosure Form answered yes? Yes [1001954102] [26-1309] Matthew Kent [Entered: 04/02/2026 09:10 AM] |
| Filing 12 APPEARANCE OF COUNSEL by Karla Doe for Sandoz Inc.. [1001953347] [26-1309] Karla Doe [Entered: 04/01/2026 10:30 AM] |
| Filing 11 DISCLOSURE STATEMENT by Immunex Corporation. Was any question on Disclosure Form answered yes? Yes [1001952946] [26-1309] Elaine Goldenberg [Entered: 03/31/2026 03:40 PM] |
| Filing 10 DISCLOSURE STATEMENT by Amgen Manufacturing Limited LLC. Was any question on Disclosure Form answered yes? Yes [1001952941] [26-1309] Elaine Goldenberg [Entered: 03/31/2026 03:39 PM] |
| Filing 9 DISCLOSURE STATEMENT by Amgen Inc.. Was any question on Disclosure Form answered yes? Yes [1001952937] [26-1309] Elaine Goldenberg [Entered: 03/31/2026 03:39 PM] |
| Filing 8 APPEARANCE OF COUNSEL by Matthew D. Kent for Sandoz Inc.. [1001952088] [26-1309] Matthew Kent [Entered: 03/30/2026 03:44 PM] |
| Filing 7 APPEARANCE OF COUNSEL by Justin P. Raphael for Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. [1001950154] [26-1309] Justin Raphael [Entered: 03/26/2026 01:14 PM] |
| Filing 6 APPEARANCE OF COUNSEL by Adam R. Lawton for Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. [1001948504] [26-1309] Adam Lawton [Entered: 03/24/2026 10:49 AM] |
| Filing 5 APPEARANCE OF COUNSEL by Sarah E. Weiner for Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. [1001948421] [26-1309] Sarah Weiner [Entered: 03/24/2026 09:30 AM] |
| Filing 4 APPEARANCE OF COUNSEL by Elaine J. Goldenberg for Amgen Inc., Amgen Manufacturing Limited LLC and Immunex Corporation. [1001948417] [26-1309] Elaine Goldenberg [Entered: 03/24/2026 09:26 AM] |
| Filing 3 BRIEFING ORDER filed. Mailed to: Ross Ritter Barton, Karla Doe, Matthew D. Kent, Jonathan Ian Kravis, Adam Russell Lawton, Scott Jeffrey Pivnick, Justin Paul Raphael, Troy A. Stram, and Faye Paul Teller. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. All filings must comply with # Appendix Pagination & Brief Citation Guide . [1001946136] Opening Brief and Appendix due 04/28/2026. Response Brief due 05/28/2026. [26-1309] KS [Entered: 03/19/2026 10:00 AM] |
| Filing 2 DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 2:25-cv-00218-AWA-RJK. Mailed to: Ross Ritter Barton, Karla Doe, Matthew D. Kent, Jonathan Ian Kravis, Adam Russell Lawton, Scott Jeffrey Pivnick, Justin Paul Raphael, Troy A. Stram, and Faye Paul Teller. [1001946113] [26-1309] KS [Entered: 03/19/2026 09:42 AM] |
| Filing 1 Case docketed. Originating case number: 2:25-cv-00218-AWA-RJK. Case manager: KStump. [1001946110] [26-1309] KS [Entered: 03/19/2026 09:39 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
